|
|
|
市場調查報告書
Biomet簡介（生物材料、大關節、小關節、脊柱、創傷、牙科）：全球地區別市場佔有率分析、SWOT分析、產品線及財務：2012年
Biomet Profile (Biomaterials, Large Joints, Small Joints, Spine & Trauma, Dental): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials 2012
|
Biomet簡介（生物材料、大關節、小關節、脊柱、創傷、牙科）：全球地區別市場佔有率分析、SWOT分析、產品線及財務：2012年 是由出版商iData Research Inc.在2011年10月所出版的。
這份英文市場調查報告書包含202 Pages 價格從美金6995起跳。
Biomet為全球五大整形外科植入體製造商之一，產品於美國、歐洲、亞洲及眾多新興市場等地銷售。運動醫學、牙科用醫療儀器等領域也拓展了其商業範圍。2011年目前，已於全球90個國家中銷售其產品，並有數十億美金之收益。
本報告為匯整Biomet公司之企業概要、業務內容、於全球整形外科生物材料、大關節、小關節、脊柱、創傷、牙科市場中之市場佔有率及地位等，以下列摘要形式闡述。
目錄
圖表
第1章 實施概要
第2章 調查方式
第3章 Biomet企業概要
- 簡介
- 企業簡介
- 業務部門
- 整形外科重建
- 整形外科創傷、脊柱、生物製劑
- 運動醫學
- 顱頜面
- 牙科
- 全球收益
- 企業歷史
- 企業資訊
第4章 財務指標
第5章 產品線
第6章 整形外科生物材料SWOT分析
第7章 整形外科生物材料市場佔有率
第8章 牙科產品之產品線
第9章 牙科SWOT分析
第10章 牙科植入體市場佔有率
第11章 牙科骨移植替代品、膜、組織工程之市場佔有率
第12章 整形外科大關節SWOT分析
第13章 大關節重建市場佔有率
第14章 小關節重建產品之產品線
第15章 小關節重建SWOT分析
第16章 小關節重建市場佔有率
第17章 小關節及整形外科創傷SWOT分析
第18章 脊柱植入體市場佔有率
第19章 整形外科創傷市場佔有率
縮寫
圖表
Abstract
Biomet is one of the five largest orthopedic implant manufacturers in the
world, with distribution in the U.S., Europe, Asia and a number of emerging
markets. Throughout its history, the company has also expanded into areas such
as sports medicine and dental medical devices. As of 2011, Biomet distributed
products in approximately 90 countries across the globe, earning revenues in
the billions. This report is a comprehensive overview of Biomet's business
activities with an in-depth analysis of the company's market share and
presence in various global orthopedic biomaterial, large joints, small joints,
spine & trauma and dental markets.
The information covered includes:
- An overview of the company history and current product divisions
- A summary of corporate financial metrics
- A review of recently approved products and the results of preliminary
clinical trials
- An in-depth review of the strengths, weaknesses opportunities and threats
(SWOT) to the company's orthopedic biomaterials divisions
- A detailed look at the market share and performance of each division in
various countries across the U.S., Europe and Asia. Whenever possible, market
share and division revenues are examined by individual country for each region
of the globe.
The key product areas covered in this report include:
- Orthopedic Bone Graft Substitutes
- Hyaluronic Acid Viscosupplementation
- Platelet and Bone Marrow Concentration Systems
- Hip Reconstruction
- Knee Reconstruction
Internal Fixation:
- Plates and Screws
- Bioabsorbable Plates and Screws
- Intramedullary Nails
- Cannulated Screws
- Conventional Hip Screws
- Intramedullary Hip Screws
- Pins, Wires and Cables
External Fixation
Long Bone Stimulators
Dental Implants
- Root-Form Dental Implants
- Non Root-Form Implants
- Dental Implant Applications
- Mini-Implants
- Dental Implant Procedures
- Dental Implant Instrument Kits
Final Abutments
- Stock Abutments
- Custom Abutments
- CAD/CAM Abutments
Dental Bone Graft Substitutes
- Autografts
- Allografts
- De-Mineralized Bone Matrix (DBM) Allografts
- Xenografts
- Synthetics
The countries covered in this report include:
- U.S.
- Germany
- France
- U.K.
- Spain
- Italy
- Benelux
- Scandinavia
- Switzerland
- Austria
- Portugal
- Japan
- Australia
- South Korea
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
1. EXECUTIVE SUMMARY
- 1.1. BIOMET OVERVIEW
- 1.2. CORPORATE REVENUE GROWTH BY BUSINESS UNIT
- 1.3. GLOBAL REVENUE BY REGION
- 1.4. GLOBAL MARKET SHARE BY MARKET SIZE
- 1.5. MARKET SHARE: DENTAL IMPLANTS AND FINAL ABUTMENTS
- 1.6. MARKET SHARE: DENTAL BONE GRAFT SUBSTITUTES
2. RESEARCH METHODOLOGY
- 2.1. IDATA'S 9-STEP METHODOLOGY
- 2.1.1. Step 1: Project Initiation & Team Selection
- 2.1.2. Step 2: Prepare Data Systems and Perform Secondary Research
- 2.1.3. Step 3: Preparation for Interviews & Questionnaire Design
- 2.1.4. Step 4: Performing Primary Research
- 2.1.5. Step 5: Research Analysis: Establishing Baseline Estimates
- 2.1.6. Step 6: Market Forecast and Analysis
- 2.1.7. Step 7: Identify Strategic Opportunities
- 2.1.8. Step 8: Final Review and Market Release
- 2.1.9. Step 9: Customer Feedback and Market Monitoring
3. BIOMET COMPANY OVERVIEW
- 3.1. INTRODUCTION
- 3.2. COMPANY PROFILE
- 3.2.1. Business Units
- 3.2.1.1. Orthopedic Reconstruction
- 3.2.1.2. Orthopedic Trauma, Spine and Biologics
- 3.2.1.3. Sports Medicine
- 3.2.1.4. Craniomaxillofacial
- 3.2.1.5. Dental
- 3.3. GLOBAL REVENUES
- 3.3.1. Global Revenues by Division
- 3.3.2. Global Revenues by Geography
- 3.4. COMPANY HISTORY
- 3.5. COMPANY INFORMATION
- 3.5.1. Size
- 3.5.2. Office and Facility Locations
4. FINANCIAL METRICS
- 4.1. INCOME STATEMENT
- 4.2. BALANCE SHEET
- 4.2.1. Balance Sheet
- 4.2.2. Company Debt
5. ORTHOPEDIC BIOMATERIALS PRODUCT PIPELINE
- 5.1. ORTHOPEDIC BIOMATERIALS
- 5.1.1. U.S. FDA Investigational Device Exemption (IDE)
- 5.1.1.1. Platelet Rich Plasmas for Tennis Elbow
- 5.1.2. U.S. FDA Phase 1 Trials
- 5.1.2.1. Bone Marrow Aspirate Concentration for Critical Limb Ischemia
- 5.1.3. U.S. FDA 510(k) Submissions
- 5.1.3.1. Bone Marrow Concentration System
- 5.1.4. European CE Mark Trials
- 5.1.4.1. ChonDux Trail Suspension
- 5.1.4.2. Fat Concentration System
6. ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS
- 6.1. ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS
- 6.1.1. Strengths
- 6.1.1.1. Joint Reconstruction
- 6.1.1.2. History in Orthopedic Biologics
- 6.1.1.3. Market Leader in Cell Concentration Systems
- 6.1.1.4. Restructured Management
- 6.1.2. Weaknesses
- 6.1.2.1. Competition from Larger Competitors
- 6.1.2.2. Lack of Advanced Bone Graft Substitute Product
- 6.1.2.3. Partial Reliance on Distributors in the United States
- 6.1.2.4. High Debt Levels
- 6.1.2.5. Spine and Trauma Fixation Divisions
- 6.1.2.6. Staff Restructuring
- 6.1.3. Opportunities
- 6.1.3.1. Undeveloped Asian and Emerging Markets Presence
- 6.1.3.2. Underdeveloped Hyaluronic Acid Viscosupplementation Potential
- 6.1.3.3. Migration to Chinese Manufacturing
- 6.1.4. Threats
- 6.1.4.1. Cost Control
- 6.1.4.2. Medical Conservatism
- 6.1.4.3. Department of Justice Sanction
- 6.1.4.4. European Sovereign Debt Crisis of 2010 and Onward
- 6.1.4.5. Potential for Acquisition
7. ORTHOPEDIC BIOMATERIALS MARKET SHARE
- 7.1. MARKET INTRODUCTION
- 7.1.1. Bone Graft Substitutes
- 7.1.1.1. Introduction
- 7.1.1.2. Indications
- 7.1.1.3. Materials
- 7.1.2. Cell Concentration
- 7.1.2.1. Introduction
- 7.1.2.2. Platelet Rich Plasma
- 7.1.2.3. Bone Marrow Aspirate
- 7.1.3. Hyaluronic Acid Viscosupplementation
- 7.1.3.1. Introduction
- 7.1.3.2. Benefits of Viscosupplementation
- 7.1.3.3. Synovial Fluid
- 7.1.3.4. Three-Injection Cycle Products
- 7.1.3.5. Five-Injection Cycle Products
- 7.1.3.6. Single-Injection Cycle Products
- 7.2. KEY PRODUCTS
- 7.2.1. Bone Graft Substitutes
- 7.2.1.1. Allograft / DBM
- 7.2.1.2. Synthetic Bone Void Fillers
- 7.2.2. Hyaluronic Acid Viscosupplementation
- 7.2.3. Cell Concentration
- 7.3. MARKET SHARE AND REVENUE ANALYSIS
- 7.3.1. Bone Graft Substitutes
- 7.3.1.1. Global Market Share
- 7.3.1.2. United States Market Share
- 7.3.1.3. European Market Share by Country
- 7.3.1.4. International Market Share
- 7.3.2. Cell Concentration (Platelet and Bone Marrow)
- 7.3.2.1. Global
- 7.3.2.2. U.S. Market Share
- 7.3.2.3. European and International Market Share
- 7.3.3. Hyaluronic Acid Viscosupplementation
- 7.3.3.1. Global
- 7.3.3.2. U.S. Market Share
- 7.3.3.3. European Market Share
- 7.3.3.4. International Market Share
8. DENTAL PRODUCT PIPELINE
- 8.1. DENTAL IMPLANTS AND BONE GRAFT SUBSTITUTES
- 8.1.1. U.S. FDA 510(k) Submissions
9. DENTAL SWOT ANALYSIS
- 9.1. DENTAL IMPLANTS, FINAL ABUTMENTS AND DENTAL BONE GRAFT SUBSTITUTES
- 9.1.1. Strengths
- 9.1.2. Weaknesses
- 9.1.3. Opportunities
- 9.1.4. Threats
10. DENTAL IMPLANTS MARKET SHARE
- 10.1. MARKET INTRODUCTION
- 10.1.1. Dental Implants
- 10.1.1.1. Root-Form Dental Implants
- 10.1.1.2. Non Root-Form Implants
- 10.1.1.3. Dental Implant Applications
- 10.1.1.4. Mini-Implants
- 10.1.1.5. Dental Implant Procedures
- 10.1.1.6. Dental Implant Instrument Kits
- 10.1.2. Introduction to Final Abutments
- 10.1.2.1. Stock Abutments
- 10.1.2.2. Custom Abutments
- 10.1.2.3. CAD/CAM Abutments
- 10.2. MARKET SHARE AND REVENUE ANALYSIS
- 10.2.1. Dental Implants and Final Abutments
- 10.2.1.1. United States Market Share
- 10.2.1.2. European Market Share
- 10.2.1.3. Asia Pacific Market Share
- 10.2.1.4. Chinese Market Share
- 10.2.1.5. Latin American Market Share
11. DENTAL BONE GRAFT SUBSTITUTES, MEMBRANES AND TISSUE ENGINEERING MARKET SHARE
- 11.1. MARKET INTRODUCTION
- 11.1.1. Applications of Dental Bone Graft Substitutes
- 11.1.1.1. Dental Implant Procedures
- 11.1.1.2. Periodontal Procedures
- 11.1.2. Types of Dental Bone Graft Substitutes
- 11.1.2.1. Autografts
- 11.1.2.2. Allografts
- 11.1.2.3. De-Mineralized Bone Matrix (DBM) Allografts
- 11.1.2.4. Xenografts
- 11.1.2.5. Synthetics
- 11.1.3. Dental Membranes
- 11.2. MARKET SHARE AND REVENUE ANALYSIS
- 11.2.1. Dental Bone Graft Substitutes
- 11.2.1.1. Global Market Share
- 11.2.1.2. U.S. Market Share
- 11.2.1.3. European Market Share
- 11.2.1.3.1. Dental Bone Graft Substitute Market Share by Country
- 11.2.1.3.2. Dental Membrane Market Share by Country
- 11.2.1.4. Asia Pacific Market Share
- ORTHOPEDIC LARGE JOINT PRODUCT PIPELINE
- 11.3. LARGE JOINT RECONSTRUCTION
- 11.3.1. U.S. FDA Investigational Device Exemption (IDE)
- 11.3.2. U.S. FDA Trials
- 11.3.3. International Trials
- 11.3.3.1. Oxford Partial Knee using Signature Custom Guides and Conventional Instrumentation
- 11.3.4. U.S. FDA 510(k) Approvals
- 11.3.4.1. Active Articulation E1
- 11.3.4.2. Signature™ Personalized Patient Care System
- 11.3.4.3. Vanguard™ Knee Prosthesis
- 11.3.4.4. Taperloc™ Hip Replacement
- 11.3.5. U.S. FDA PMA Approval Updates
- 11.3.5.1. Oxford™ Partial Knee
12. ORTHOPEDIC LARGE JOINT SWOT ANALYSIS
- 12.1. LARGE JOINT RECONSTRUCTION SWOT ANALYSIS
- 12.1.1. Strengths
- 12.1.2. Weaknesses
- 12.1.3. Opportunities
- 12.1.4. Threats
- 12.1.4.1. Troubled Global Economy
13. LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS
- 13.1. MARKET INTRODUCTION
- 13.1.1. Knee Reconstruction
- 13.1.1.1. Anatomy
- 13.1.1.2. Pathology
- 13.1.1.3. Implant Types
- 13.1.1.3.1. Total Knee Replacement
- 13.1.1.3.2. Partial Knee Replacement
- 13.1.1.3.3. Patellofemoral Replacement
- 13.1.1.3.4. Interpositional Knee Implants
- 13.1.1.3.5. Knee Revision
- 13.1.1.4. Fixation Method
- 13.1.1.5. Bearing Surface
- 13.1.1.6. Fixed verses Mobile Bearings
- 13.1.2. Hip Reconstruction
- 13.1.2.1. Anatomy
- 13.1.2.2. Pathology
- 13.1.2.3. Treatment
- 13.1.2.4. Implant Types
- 13.1.2.4.1. Total Hip Joint Replacement
- 13.1.2.4.2. Partial Hip Joint Replacement
- 13.1.2.4.3. Resurfacing Hip Joint Replacement
- 13.1.2.4.4. Revision Hip Joint Replacement
- 13.1.2.5. Fixation Method
- 13.1.2.6. Implant Material
- 13.1.2.7. Bearing Surface Technology
- 13.1.2.7.1. Polyethylene Bearings
- 13.1.2.7.2. Highly Cross-Linked Polyethylene Bearings
- 13.1.2.7.3. Metal Bearings
- 13.1.2.7.4. Ceramic Bearings
- 13.2. MARKET SHARE AND REVENUE ANALYSIS
- 13.2.1. Combined Large Joint Reconstruction
- 13.2.1.1. Global Market Share
- 13.2.1.2. U.S. Market Share
- 13.2.1.3. European Market Share by Country
- 13.2.1.4. Asian Market Share by Country
- 13.2.2. Hip Reconstruction
- 13.2.2.1. Global Market Share
- 13.2.2.2. Asia Pacific Market Share
- 13.2.3. Knee Reconstruction
- 13.2.3.1. Global
- 13.2.3.2. Asia Pacific Market Share
14. SMALL JOINT RESONSTRUCTION PRODUCT PIPELINE
- 14.1. SMALL JOINT RECONSTRUCTION
- 14.1.1. U.S. FDA 510(k) Approvals
- 14.1.1.1. Bio-Modular™ Reverse Shoulder
15. SMALL JOINT RECONSTRUCTION SWOT ANALYSIS
- 15.1. SMALL JOINT RECONSTRUCTION SWOT ANALYSIS
- 15.1.1. Strengths
- 15.1.2. Weaknesses
- 15.1.3. Opportunities
- 15.1.4. Threats
16. SMALL JOINT RECONSTRUCTION MARKET SHARE
- 16.1. MARKET INTRODUCTION
- 16.1.1. Introduction
- 16.1.2. Anatomy and Pathology
- 16.1.2.1. Osteoarthritis
- 16.1.2.2. Inflammatory Arthritis
- 16.1.3. Treatment
- 16.1.3.1. Arthroplasty
- 16.1.3.2. Ostectomy
- 16.1.3.3. Internal Fixation
- 16.1.3.4. External Fixation
- 16.1.4. Treatment Devices
- 16.1.4.1. Shoulder Joint Reconstruction Devices
- 16.1.4.2. Elbow Joint Reconstruction
- 16.1.4.3. Hand and Wrist Devices
- 16.1.4.4. Foot and Ankle Devices
- 16.1.4.5. Digit Replacement
- 16.1.4.6. Cannulated Screws and Plate Fixation Devices
- 16.2. KEY PRODUCTS
- 16.2.1. Shoulder Reconstruction
- 16.2.2. Elbow Reconstruction
- 16.2.3. Wrist Replacement
- 16.3. MARKET SHARE AND REVENUE ANALYSIS
- 16.3.1. Small Joint Reconstruction
- 16.3.1.1. Global Market Share
- 16.3.1.2. United States Market Share
- 16.3.1.3. European Market Share
- 16.3.1.3.1. European Shoulder Reconstruction Market Share by Country
- 16.3.1.4. Japanese Market Share
- SPINAL IMPLANT AND ORTHOPEDIC TRAUMA PRODUCT PIPELINE
- 16.4. SPINAL IMPLANTS
- 16.4.1. U.S. FDA 510(k) Submissions
- 16.4.1.1. Polaris™ Spinal System, Intervertebral
- 16.4.1.2. Polaris™ Spinal System, Pedicle
- 16.4.1.3. Zyston™ Arc Interbody Spacer
- 16.5. ORTHOPEDIC TRAUMA
- 16.5.1. U.S. FDA 510(k) Submissions
- 16.5.1.1. Multi-Axial Correction (Mac) Male Adapter
- 16.5.1.2. MaestroTM Wrist Plating System
- 16.5.1.3. ExplorR Radial Head Plating System
- 16.5.1.4. ComprehensiveTM Proximal Humeral Plating System
17. SPIMAL IMPLANT AND ORTHPEDIC TRAUMA SWOT ANALYSIS
- 17.1. SPINAL IMPLANTS AND TRAUMA FIXATION SWOT ANALYSIS
- 17.1.1. Strengths
- 17.1.2. Weaknesses
- 17.1.3. Opportunities
- 17.1.4. Threats
18. SPINAL IMPLANTS MARKET SHARE
- 18.1. MARKET INTRODUCTION
- 18.1.1. Introduction
- 18.1.1.1. Spinal Fusion
- 18.1.1.2. Traditional Interbody Fusion
- 18.1.1.2.1. ALIF
- 18.1.1.2.2. PLIF
- 18.1.1.2.3. TLIF
- 18.1.1.2.4. CIF
- 18.1.1.3. Minimally Invasive Interbody Fusion
- 18.1.1.3.1. Minimally Invasive TLIF (MITLIF)
- 18.1.1.3.2. Minimally Invasive PLIF (MIPLIF)
- 18.1.1.3.3. Lateral Lumbar Interbody Fusion (LLIF)
- 18.1.1.4. Motion Preservation
- 18.1.1.4.1. Artificial Discs
- 18.1.1.4.2. Posterior Dynamic Stabilization
- 18.1.1.4.3. Interspinous Process Decompression
- 18.1.1.4.4. Nucleus Replacement
- 18.1.1.4.5. Annular Repair
- 18.1.1.4.6. Facet Arthroplasty
- 18.1.1.5. Vertebral Compression Fracture (VCF)
- 18.1.1.6. Electrical Stimulation
- 18.2. KEY PRODUCTS
- 18.2.1. Cervical
- 18.2.2. Thoracolumbar
- 18.2.3. Spacers
- 18.2.4. Vertebroplasty
- 18.3. MARKET SHARE AND REVENUE ANALYSIS
- 18.3.1. Spinal Implants
- 18.3.1.1. Global Market Share
- 18.3.1.2. U.S. Market Share
- 18.3.1.3. European Market Share
- 18.3.1.4. Asia Pacific and Latin America
19. ORTHOPEDIC TRAUMA MARKET SHARE
- 19.1. MARKET INTRODUCTION
- 19.1.1. Anatomy and Pathology
- 19.1.1.1. Anatomy
- 19.1.1.2. Pathology and Healing
- 19.1.2. Treatment Overview
- 19.1.2.1. Internal Fixation
- 19.1.2.2. External Fixation
- 19.1.2.3. Bone Growth Stimulation
- 19.1.3. Internal Fixation
- 19.1.3.1. Plates and Screws
- 19.1.3.2. Bioabsorbable Plates and Screws
- 19.1.3.3. Intramedullary Nails
- 19.1.3.4. Cannulated Screws
- 19.1.3.5. Conventional Hip Screws
- 19.1.3.6. Intramedullary Hip Screws
- 19.1.3.7. Pins, Wires and Cables
- 19.1.4. External Fixation
- 19.1.5. Long Bone Stimulators
- 19.2. KEY PRODUCTS
- 19.2.1. Internal Plates and Screws
- 19.2.2. Hip Fracture Screws
- 19.2.3. Intramedullary Nails
- 19.2.4. External Fixation
- 19.3. MARKET SHARE AND REVENUE ANALYSIS
- 19.3.1. Trauma Fixation
- 19.3.1.1. Global Market Share
- 19.3.1.2. United States Market Share
- 19.3.1.3. European Market Share
- 19.3.1.4. Japanese Market Share
ABBREVIATIONS
LIST OF FIGURES
EXECUTIVE SUMMARY
RESEARCH METHODOLOGY
BIOMET COMPANY OVERVIEW
- Figure 3-1: Global Revenues by Division, Biomet, (US$M), 2010 - 2011
- Figure 3-2: Global Revenues Growth by Division, Biomet, 2011
- Figure 3-3: Global Market Share and Revenue Growth by Market Size, Biomet
(US$M), 2011
- Figure 3-4: Global Revenues by Geography, Biomet, (US$M), 2010 - 2011
- Figure 3-5: Company Size, Biomet, 2011
- Figure 3-6: Key Facilities, Biomet, 2011
FINANCIAL METRICS
- Figure 4-1: Income Statement, Biomet, 2009 - 2011 (US$M)
- Figure 4-2: Balance Sheet, Biomet, 2009 - 2011 (US$M)
- Figure 4-3: Company Debt, Biomet, 2011 (US$M)
ORTHOPEDIC BIOMATERIALS PRODUCT PIPELINE
ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS
ORTHOPEDIC BIOMATERIALS MARKET SHARE
- Figure 7-1: Bone Graft Substitutes Market Share, Biomet, 2011 (US$M)
- Figure 7-2: Bone Graft Substitutes Market Share by Country, Europe,
Biomet, 2011 (US$M)
- Figure 7-3: Cell Concentration Market Share, Biomet, 2011
- Figure 7-4: Hyaluronic Acid Viscosupplementation Market Share by Country,
Biomet, 2011 (US$M)
DENTAL PRODUCT PIPELINE
DENTAL SWOT ANALYSIS
DENTAL IMPLANTS MARKET SHARE
- Figure 7-1: Market Share, Biomet, 2011 (US$M)
- Figure 7-2: Market Share by Country, Europe, Biomet, 2011 (US$M)
- Figure 7-3: Market Share by Country, Asia Pacific, Biomet, 2011 (US$M)
- Figure 7-4: Market Share by Country, Latin America, Biomet, 2011 (US$M)
DENTAL BONE GRAFT SUBSTITUTES, MEMBRANES AND TISSUE ENGINEERING MARKET SHARE
- Figure 8-1: Market Share, Biomet, 2011 (US$M)
- Figure 8-2: Dental Bone Graft Substitute Market by Country, Europe, 2011
(US$M)
- Figure 8-3: Dental Membrane Market by Country, Europe, 2011 (US$M)
ORTHOPEDIC LARGE JOINT PRODUCT PIPELINE
ORTHOPEDIC LARGE JOINT SWOT ANALYSIS
LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS
- Figure 7-1: Large Joint Reconstruction Market Share, Biomet, 2011 (US$M)
- Figure 7-2: Large Joint Reconstruction Market Share, Europe, Biomet, 2011
(US$M)
- Figure 7-3: Large Joint Reconstruction Market Share, Asia, Biomet, 2011
(US$M)
- Figure 7-4: Hip Reconstruction Market Share, Biomet, 2011 (US$M)
- Figure 7-5: Hip Reconstruction Market Share by Country, Europe, Biomet,
2011 (US$M)
- Figure 7-6: Hip Reconstruction Market Share by Country, Asia, Biomet, 2011
(US$M)
- Figure 7-7: Knee Reconstruction Market Share, Biomet, 2011
- Figure 7-8: Hip Reconstruction Market Share, Biomet, 2011
- Figure 7-9: Knee Reconstruction Market Share, Biomet, 2011
SMALL JOINT RESONSTRUCTION PRODUCT PIPELINE
SMALL JOINT RECONSTRUCTION SWOT ANALYSIS
SMALL JOINT RECONSTRUCTION MARKET SHARE
- Figure 7-1: Small Joint Reconstruction Market Share, Biomet, 2011 (US$M)
- Figure 7-2: Shoulder Reconstruction Market Share, Europe, 2011 (US$M)
SPINAL IMPLANT AND ORTHOPEDIC TRAUMA PRODUCT PIPELINE
SPIMAL IMPLANT AND ORTHPEDIC TRAUMA SWOT ANALYSIS
SPINAL IMPLANTS MARKET SHARE
- Figure 7-1: Spinal Implants Market Share, Biomet, 2011 (US$M)
ORTHOPEDIC TRAUMA MARKET SHARE
- Figure 8-1: Orthopedic Trauma Market Share, Biomet, 2011 (US$M)
ABBREVIATIONS
LIST OF CHARTS
EXECUTIVE SUMMARY
- Chart 1-1: Business Unit Revenue by Percentage, Biomet, 2011
- Chart 1-2: Annual Revenue Growth by Business Unit, Biomet, 2011
- Chart 1-3: Percentage of Global Revenues by Region, Biomet, 2011
- Chart 1-4: Global Market Share and Revenue Growth by Market Size, Biomet
(US$M), 2011
- Chart 1-5: Global Dental Implants and Final Abutments Market Share,
Biomet, 2011
- Chart 1-6: Global Dental Bone Graft Substitutes Market Share, Biomet, 2011
RESEARCH METHODOLOGY
BIOMET COMPANY OVERVIEW
- Chart 3-1: Global Revenues by Division, Biomet, 2011
- Chart 3-2: Global Revenue Growth by Division, Biomet, 2011
- Chart 3-3: Global Market Share and Revenue Growth by Market Size, Biomet
(US$M), 2011
- Chart 3-4: Global Revenues by Geography, Biomet, 2011
- Chart 3-5: Countries with Key Administrative and Manufacturing Facilities,
Biomet, 2011
FINANCIAL METRICS
ORTHOPEDIC BIOMATERIALS PRODUCT PIPELINE
ORTHOPEDIC BIOMATERIALS SWOT ANALYSIS
ORTHOPEDIC BIOMATERIALS MARKET SHARE
- Chart 7-1: Global Bone Graft Substitutes Market Share, Biomet, 2011
- Chart 7-2: Bone Graft Substitutes Market Share by Region, Biomet, 2011
- Chart 7-3: Global Cell Concentration Market Share, Biomet, 2011
- Chart 7-4: Cell Concentration Market Share by Region, Biomet, 2011
- Chart 7-5: Global Hyaluronic Acid Viscosupplementation Market Share
Biomet, 2011
- Chart 7-6: Hyaluronic Acid Viscosupplementation Market Share by Country,
Biomet, 2011
DENTAL PRODUCT PIPELINE
DENTAL SWOT ANALYSIS
DENTAL IMPLANTS MARKET SHARE
- Chart 7-1: Global Dental Implant Market Share, Biomet, 2011
- Chart 7-2: Dental Implant Market Share by Region, Biomet, 2011
DENTAL BONE GRAFT SUBSTITUTES, MEMBRANES AND TISSUE ENGINEERING MARKET SHARE
- Chart 8-1: Global Bone Graft Substitutes Market Share, Biomet, 2011
- Chart 8-2: Bone Graft Substitutes Market Share by Region, Biomet, 2011
ORTHOPEDIC LARGE JOINT PRODUCT PIPELINE
ORTHOPEDIC LARGE JOINT SWOT ANALYSIS
LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS
- Chart 7-1: Global Large Joint Reconstruction Market Share, Biomet, 2011
(US$M)
- Chart 7-2: Large Joint Reconstruction Market Share by Region, Biomet, 2011
(US$M)
- Chart 7-3: Global Hip Reconstruction Market Share, Biomet, 2011
- Chart 7-4: Hip Reconstruction Market Share by Region, Biomet, 2011
- Chart 7-5: Global Knee Reconstruction Market Share, Biomet, 2011
SMALL JOINT RESONSTRUCTION PRODUCT PIPELINE
SMALL JOINT RECONSTRUCTION SWOT ANALYSIS
SMALL JOINT RECONSTRUCTION MARKET SHARE
- Chart 7-1: Global Small Joint Reconstruction Market Share, Biomet, 2011
- Chart 7-2: Small Joint Reconstruction Market Share by Region, Biomet, 2011
SPINAL IMPLANT AND ORTHOPEDIC TRAUMA PRODUCT PIPELINE
SPIMAL IMPLANT AND ORTHPEDIC TRAUMA SWOT ANALYSIS
SPINAL IMPLANTS MARKET SHARE
- Chart 7-1: Global Spinal Implants Market Share, Biomet, 2011
- Chart 7-2: Spinal Implants Market Share by Region, Biomet, 2011
ORTHOPEDIC TRAUMA MARKET SHARE
- Chart 8-1: Global Orthopedic Trauma Market Share, Biomet, 2011
- Chart 8-2: Orthopedic Trauma Market Share by Region, Biomet, 2011
ABBREVIATIONS
|
 |
